Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06214221 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Using Signos mHealth Platform in Adults for Weight Management

Study acronym: SWEET
StatusActive, Not Recruiting
PhaseNot applicable
SponsorSignos Inc
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 8, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Jun 30, 2025 to Apr 30, 2026v4
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 5 of 5 sites
    v3
  3. Eligibility criteria expanded, about 1 wordv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Signos Inc
3 trials monitored
See all monitored trials
Obesity
3,874 trials monitored
See 152 trials at risk
Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral changes efforts, leading to improved adherence and results from diet and exercise changes in individuals with obesity. Mobile health (mHealth) platforms provide satisfactory, easy-to-use tools that help participants in the pursuit of weight change goals. The investigators hypothesize that the use of CGM data and targeted coaching and nutrition education will assist with weight optimization goals in the general (non-diabetic) population using the Signos mHealth platform, with associated health benefits.
Trial Details
NCT Number NCT06214221
Lead Sponsor Signos Inc
Collaborators: Lindus Health, Inc.
Conditions
(from sponsor)		 Overweight and Obesity, Metabolic Syndrome, Weight Loss
Related terms Metabolic Syndrome, Obesity, Overweight, Weight Loss
Enrollment 380 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov